Megan Herber

Faegre Drinker Biddle & Reath LLP

+ Follow Contact

Latest Posts › Food and Drug Administration (FDA)

Share:

Fall 2022 Federal Healthcare Legislative Landscape

With President Biden signing the Inflation Reduction Act (IRA) into law on August 16, the next big question is what the last third of 2022 will bring. Enacting the IRA takes the “will it or won’t it happen” issue of...more

8/26/2022 / Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Inflation Reduction Act (IRA) , Medicare , Telehealth , User Fees

Outlook for the 2022 Federal Health Legislative Landscape

As the 117th Congress moves into its second legislative session, there is no shortage of health care policy issues dotting the landscape. The COVID-19 pandemic, legislative gridlock and a 2021 that was largely locked down by...more

1/11/2022 / Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Medicaid , Medicare , PDUFA , Prescription Drugs , Telehealth , User Fees

To Address Mental Health Amid COVID-19, FDA Looks Digital

Social distancing measures during the COVID-19 pandemic have profoundly impacted the way health care services are delivered. In order to reduce risk to both health care providers and to patients, as many services as possible...more

4/20/2020 / Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medical Devices , Mental Health

3 Results

View per page

Page: of 1